Skip to content

Development of Optical Biometer

Development of a Next-Generation Optical Biometer for Eyes With Cataract

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07325162
Acronym
CH-0203
Enrollment
100
Registered
2026-01-08
Start date
2025-11-07
Completion date
2026-03-30
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract and IOL Surgery

Keywords

Optical Biometer, SS-OCT

Brief summary

The Helioscope (Cassini Technologies B.V.) is a novel device under development that aims at combining LED-based corneal topography and SS-OCT to provide accurate and fast measurements of both the corneal shape and the ocular biometry. To that end, the hardware and software of the Cassini color-LED topographer (Cassini Technologies B.V.) is combined with a novel SS-OCT device. While the new Helioscope can largely be evaluated using data acquired with healthy eyes, one of its main use-cases is providing input for IOL power formulae for cataract surgery. Thus, it is essential that the device can perform measurements in eyes with (dense) cataract. As cataract changes the optical properties of the crystalline lens and the OCT measurement is optical, this is not a given. This study therefore seeks a dataset of Helioscope measurements performed in eyes with cataract that can be used to develop the software algorithms of the Helioscope.

Interventions

DEVICENew Investigational Optical Biometer (Device)

Investigational optical biometer used to obtain axial length, keratometry, anterior chamber depth, lens thickness, and total corneal astigmatism. Device is being evaluated for measurement accuracy and agreement.

DEVICEComparator Device A (Cassini Ambient)

FDA-cleared corneal topographer used as a reference standard comparator for keratometry.

DEVICEomparator Device B (Argos)

FDA-cleared optical biometer used as a second comparator to assess agreement and measurement differences.

Sponsors

Cassini Technologies
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The presence of cataract in at least one eye. * Minimally 21 years of age. * Provided written informed consent.

Exclusion criteria

* The inability to properly fixate on a fixation target for several seconds * The inability to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Ocular parameters of cataractous eyes measured with a novel biometerOverall study to complete up to 12 monthsPrimary endpoint: Biometric ocular parameters of axial length, anterior chamber depth, central corneal thickness, keratometry, lens thickness and limbal white to white will be measured by the Helioscope device in 200 eyes.

Secondary

MeasureTime frameDescription
Comparison of ocular biometry measured by a novel biometer against FDA approved devices for planning cataract surgeryOverall study to complete up to 12 monthsOcular biometric values (axial length, anterior chamber depth, keratometry, limbal white to white, lens thickness, and central corneal thickness - measured in millimetres) measured by the Helioscope device will be compared against the same values captured by the Argos biometer and Ambient topographer devices (both FDA approved devices on label use) in 200 eyes.

Countries

United States

Contacts

Primary ContactDr. Michael Petrik Petrik, OD
m.petrik@cassini-technologies.com236-982-8672

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026